The stable rating outlook reflects our expectation that Nan Shan Life's capital and earnings will remain satisfactory over the next two years, supported by moderate premium growth that focuses on long-tenor, protection type products. In addition, we believe Nan Shan Life will maintain its investment risk exposure through close monitoring and proactive risk control amid volatile market conditions. We anticipate no structural change on the investment mix, but a slight increase in equity exposure for the next two years. In our view, the insurer's operations will remain independent of its two main shareholders--Taiwan-based Ruentex and Pou Chen Corp. groups--under Taiwan's regulatory framework for financial service sectors. We may lower the ratings on Nan Shan Life if: The insurer pursues aggressive